Subscribe

  • How Can We Help You?

    Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

2017 End-of-Year Summary of FDA Advertising and Promotion Enforcement Activity

Alert January 26, 2018

  • News and Insights
  • 2017 End of Year Summary of FDA Advertising and Promotion Enforcement Activity

2017 End-of-Year Summary of FDA Advertising and Promotion Enforcement Activity

January 26, 2018, Covington Alert

This e-alert reviews trends emerging from warning letters and untitled letters concerning therapeutic product advertising and promotion issued in 2017 by the Office of Prescription Drug Promotion (OPDP) of the Center for Drug Evaluation and Research (CDER), the Office of Compliance and Biologics Quality (OCBQ) of the Center for Biologics Evaluation and Research (CBER), and the Office of Compliance (OC) of the Center for Devices and Radiological Health (CDRH). OCBQ did not issue any advertising and promotion enforcement letters in 2017.

View More

Related Professionals

Share links:

Share links:

Related Practices

Related Offices

Related Regions

Related News & Insights